Sarepta Therapeutics
$11.13 B
Share price
Change (1 day)
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) Fails to deliver data

Key failure to deliver metrics for Sarepta Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Sarepta Therapeutics (SRPT) - 3 month history

Number of shares, 3 month chart

Biweekly Failures to deliver volume for Sarepta Therapeutics (SRPT) - since 2013

Volume in USD (price x number of shares), data since 2013

Sarepta Therapeutics (SRPT) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2023$20.23 M0.19%
2022$20.2 M-64.04%
2021$56.17 M-40.62%
2020$94.6 M-66.33%
2019$0.28 B16.72%
2018$0.24 B253.79%
2017$68.05 M-40.35%
2016$0.11 B190.97%
2015$39.21 M-69.48%
2014$0.12 B79.12%
2013$71.71 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
$78.8 M$0.18 B๐Ÿ‡บ๐Ÿ‡ธ USA
$2.81 M$7.88 M๐Ÿ‡บ๐Ÿ‡ธ USA
$59.36 M$0.28 B๐Ÿ‡บ๐Ÿ‡ธ USA
$0.62 M$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
$7.85 M$12.72 M๐Ÿ‡บ๐Ÿ‡ธ USA
$0.93 M$7.98 M๐Ÿ‡บ๐Ÿ‡ธ USA
$0.31 M$16.46 M๐Ÿ‡บ๐Ÿ‡ธ USA